The Oral Apelin Receptor Agonist Azelaprag Enhances Glycemic Control in Preclinical Models of Diabetic Obesity Both as Monotherapy and in Combination with Tirzepatide

azelaprag (BGE-105) - BioAge Labs

Mounjaro (tirzepatide) - Eli Lilly

https://eppro02.ativ.me/web/page.php?page=IntHtml&project=ADA25&id=691

PAUL RUBIN; YAN WANG; SHIJUN YAN; MATTHEW BANICKI; MARY COCHRAN; CLAUDIA PORTILLO; CARL RODRIGUEZ; ANDREW BANICKI; ALLISON RITTER; GABRIEL GUERRERO; SAMANTHA COWDIN; CHRISTOPHER PATIL; JUSTIN REBO; RUSTY MONTGOMERY; ERIC MORGEN; KRISTEN FORTNEY

Mar 30, 2025